Maxim Maheux




Full Name

Maxim Maheux

Academic Profile


Developing research projects to help companies in developing pre-clinical toxicity and pharmacological studies and test the efficacy components for these companies

Long description

Mr. Maxim Maheux joined the TransBIOTech team in 2000 as a technician in analytical chemistry. In 2008 he completed studies in chemistry and works as a chemist in charge of the chemistry sector in the center and professional researcher in organic chemistry. He completed in 2012 a Master of metabolomics and he began a PhD in Pharmaceutical Sciences; he is the contact person for this activity sector.

Type of institution



201 Rue Monseigneur-Bourget, Levis, QC, Canada



I have a knowledge mobilization grant.




Agriculture, forestry, fishing and hunting

Animal production and aquaculture


Chemical manufacturing

Health care and social assistance


Video Transcript


Transcript (English)

Introduce your team

Hello, my name is Sarah Paris Robidas. I work as a researcher in pharmaceutical sciences at Transbiotech.

Explain its significance

So here, my main mandate will be to set up and develop research projects to help companies in developing pre-clinical tests. We mainly work in toxicity studies, pharmacological studies, and also to develop models to test the efficacy of different components for these companies.

We offer different animal models, whether they be hamsters, mice, rates. They can be cancer models or models of inflammatory diseases such as Crohns. We also have dermatitis models.

Transcript (French)

Introduisez votre équipe

Bonjour, je m’appelle Sarah Paris Robidas. Je travaille comme chercheur dans le secteur des sciences pharmaceutiques à Transbiotech.

Quelle est son importance

Donc ici, principalement, mon mandat ça va être de monter et développer des projets de recherche pour aider à accompagner les compagnies en développement pré-clinique.

Principalement on va intervenir au niveau des études de toxicité, des études de pharmacocinétique, puis aussi on va travailler beaucoup à développer des modèles pour tester l’efficacité des différents composés pour ces compagnies. Donc on va offrir différents modèles animaux soit hamsters, souris ou rats. Donc ça va être des modèles de cancers maladies inflammatoires comme la maladie de Crohn, on va aussi avoir des modèles de dermatite.